Lexaria Bioscience Corp. - COM NEW (LEXX)

CUSIP: 52886N406

Q2 2025 13F Holders as of 30 Jun 2025

Type / Class
Equity / COM NEW
Total 13F shares
2,297,450
Share change
+1,057,694
Total reported value
$1,999,388
Price per share
$0.87
Number of holders
21
Value change
+$851,079
Number of buys
9
Number of sells
5

Quarterly Holders Quick Answers

What is CUSIP 52886N406?
CUSIP 52886N406 identifies LEXX - Lexaria Bioscience Corp. - COM NEW in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Lexaria Bioscience Corp. - COM NEW (LEXX) as of Q2 2025

As of 30 Jun 2025, Lexaria Bioscience Corp. - COM NEW (LEXX) was held by 21 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 2,297,450 shares. The largest 10 holders included SABBY MANAGEMENT, LLC, Invenomic Capital Management LP, GEODE CAPITAL MANAGEMENT, LLC, VANGUARD GROUP INC, TORONTO DOMINION BANK, STATE STREET CORP, Byrne Asset Management LLC, WEALTH ENHANCEMENT ADVISORY SERVICES, LLC, BlackRock, Inc., and NORTHERN TRUST CORP. This page lists 21 institutional shareholders reporting positions in this security for the Q2 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.